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Gram-negative bacteria use siderophores, outer membrane receptors, inner
membrane transporters and substrate-binding proteins (SBPs) to transport
transition metals through the periplasm. The SBPs share a similar protein fold
that has undergone significant structural evolution to communicate with a
variety of differentially regulated transporters in the cell. In Yersinia pestis, the
causative agent of plague, YfeA (YPO2439, y1897), an SBP, is important for full
virulence during mammalian infection. To better understand the role of YfeA in
infection, crystal structures were determined under several environmental
conditions with respect to transition-metal levels. Energy-dispersive X-ray
spectroscopy and anomalous X-ray scattering data show that YfeA is
polyspecific and can alter its substrate specificity. In minimal-media experiments,
YfeA crystals grown after iron supplementation showed a threefold increase in
iron fluorescence emission over the iron fluorescence emission from YfeA
crystals grown from nutrient-rich conditions, and YfeA crystals grown after
manganese supplementation during overexpression showed a fivefold increase
in manganese fluorescence emission over the manganese fluorescence emission
from YfeA crystals grown from nutrient-rich conditions. In all experiments, the
YfeA crystals produced the strongest fluorescence emission from zinc and could
not be manipulated otherwise. Additionally, this report documents the discovery
of a novel surface metal-binding site that prefers to chelate zinc but can also
bind manganese. Flexibility across YfeA crystal forms in three loops and a helix
near the buried metal-binding site suggest that a structural rearrangement is
required for metal loading and unloading.
1. Introduction
In Gram-negative bacteria, the periplasm plays a crucial role
in the homeostasis of essential transition metals by serving as a
nutrient bank to supply or deplete the cytoplasm (Andrews et
al., 2003). When resources are limited, extracellular metal ions
are sequestered and returned to the cell by high-affinity metal-
chelating siderophores and cognate receptors (Andrews et al.,
2003). Trafficking of transition-metal ions through the peri-
plasm is mitigated by siderophores and substrate-binding
proteins (SBPs; Couñago et al., 2012). SBPs similarly chelate
and deliver metal ions to inner membrane transporters for
passage into the cytoplasm (Argüello et al., 2011). For
pathogenic bacteria, infection presents significant challenges
in acquiring nutrients, as metals are in variable abundance
according to the site of infection and pathogens must compete
with the host for essential metals (Ma et al., 2009).
ISSN 2059-7983
SBPs must have high substrate specificity for the precise
regulation of any nutrient and its downstream functions
(Lawson et al., 1998). These polypeptides follow a general
c-clamp fold made up of two / globular domains that are
connected by an -helical backbone linking region and inter-
domain hinges composed of -strands (Couñago et al., 2012).
SBPs also have a canonical metal ion-binding site that is made
up of ligands from each domain (Quiocho & Ledvina, 1996).
Metal-binding events may help to stabilize some SBPs by
reducing disorder and constraining each globular domain to
occupy a single position. Evolution of the c-clamp fold has
created diversity in backbone length and SBP size and led to a
structural medley of dumbbell and horseshoe morphologies
(Fig. 1). The geometry of the c-clamp is likely to have func-
tional relevance in both the recognition of related inner
membrane components as well as metal transport. The SBP
structure also determines how deeply buried or exposed a
metal-binding site is and may influence metal affinity and
exchange. Bacterial systems for nutrient acquisition present
intriguing therapeutic targets because transition metals are
required for catalysis, replication, metabolism, structure and
other functions (Palmer & Skaar, 2016). Many of these
systems are semi-redundant, such that the inhibition of one
system is compensated by a related system that transports the
same substrate (Plumptre et al., 2014). Despite this semi-
redundancy, some transporters appear to be more critical to
cell vitality than others and present stronger phenotypes when
inhibited or deleted (Desrosiers et al., 2010). The Yfe/Sit
family of ABC transporters are widespread iron and
manganese transporters that play a role in the virulence of a
number of pathogens (Bearden & Perry, 1999; Perry et al.,
2012; Fetherston et al., 2012). Animal and human serum
studies show that yfeA, a gene encoding a polyspecific SBP, is
among the most upregulated genes in Yersinia pestis during
bubonic and septicemic plague infection (Rosso et al., 2008;
Perry et al., 2015). Biochemical analysis indicates that the Yfe
system transports manganese and iron, and complements
their respective transporters MntH and FeoABC. Double
(yfe feo and yfe mntH) mutants but not single mutants
are significantly attenuated in mouse models of bubonic
plague (Bearden & Perry, 1999; Perry et al., 2007, 2012;
Fetherston et al., 2012).
Historically, SBPs were first organized into protein classes
that were distinguished by the topology of -sheets in the
globular domains and the connectivity of secondary-structural
elements (Fukami-Kobayashi et al., 1999). Over the last two
decades, the number of SBP structures has dramatically
increased, prompting a new cluster system to classify SBPs
based on both structural and functional properties. In 2010,
Berntsson and coworkers established the modern cluster
system of SBP classification that contained six distinct clusters
(A–F), and in 2016 Scheepers and coworkers updated the
cluster system with a new, seventh cluster (G), underscoring
the diversity of SBPs that continues to grow through discovery
(Berntsson et al., 2010; Scheepers et al., 2016). Of the seven
clusters of SBPs, clusters A and D contain SBPs involved in
transition-metal homeostasis. Cluster A-1 contains SBPs that
bind metal ions directly, cluster A-2 contains SBPs that bind
chelated metal ions via siderophores, and cluster D-4 contains
SBPs that bind metal ions directly via a synergistic anion
(Berntsson et al., 2010). A key engine to driving SBP structural
investigations has been the use of Escherichia coli to produce
recombinant SBPs from many genera (Lee et al., 1999; Ilari et
al., 2011; McDevitt et al., 2011; Gribenko et al., 2013; Handali
et al., 2015), including Yersinia pestis (Shouldice et al., 2005).
E. coli has been reliably used to generate recombinant protein
that is physiologically relevant and useful for biotechnological
applications, namely drug discovery (Lu et al., 2012; Sanapala
et al., 2016). E. coli is particularly useful to study the biology of
Y. pestis proteins because both E. coli and Y. pestis are Gram-
negative organisms that have similar physiologies and utilize
similar cellular machinery. In this work, we report the three-
dimensional atomic structure of YfeA, a cluster A-1 SBP, and
the discovery of a surface polyspecific metal-binding site that
appears to be unique to the Y. pestis ortholog, although its
function is unknown. We demonstrate by X-ray fluorescence,
referred to as energy-dispersive X-ray spectroscopy (EDS),
and anomalous X-ray scattering that YfeA specificity at the
canonical site is environmentally sensitive. We also present a
research papers
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Figure 1
Evolution of the SBP c-clamp. The general structure of an SBP is a
c-clamp. The c-clamp has undergone significant structural evolution. The
conformational range that this structure can occupy includes a compact
cleft resembling a stone (PDB entry 1xvx; Shouldice et al., 2005), an
elongated cleft resembling a dumbbell (PDB entry 4wed; New York
Structural Genomics Research Consortium, unpublished work) and clefts
with more curvature that resemble horseshoes (PDB entries 2xy4 and
5cr9; Ilari et al., 2011; Midwest Center for Structural Genomics,
unpublished work). Models for each morphology are included below
the respective PDB codes. If a structure is metal-bound, the metal sphere
is shown and is colored by CPK chemical convention.
model for loading and unloading the canonical site based on
conformational changes captured from multiple YfeA crystal
morphologies.
2. Materials and methods
2.1. Cloning, overexpression and purification of YfeA-H10
The yfeA gene (UniProt reference Q56952) was synthesized
by and purchased from GenScript (Piscataway, New Jersey,
USA) and was inserted into a standard pET-22b vector
(Novagen; catalog No. 69744) using NdeI and XhoI cloning
sites. In this construct, the vector containing the yfeA insertion
also codes for a C-terminal His10 tag and is expressible in
E. coli. The plasmid was recovered from ampicillin-resistant
E. coli colonies and the DNA sequence was verified by the
University of Alabama at Birmingham Heflin Center Geno-
mics Core Laboratories. The plasmid was transformed into
E. coli strain BL21(DE3)pLysS Singles competent cells
(Novagen; catalog No. 70236). The transformed cells were
grown in LB containing 50 mg ml1 ampicillin with shaking at
225 rev min1 at 37C. When the OD600 reached 0.5–0.6, the
temperature was reduced to 16C and overexpression of
YfeA-His10 was induced for 16 h with 1 mM isopropyl -d-1-
thiogalactopyranoside (IPTG). The same method was used for
overexpression in M9 minimal medium (Amresco; catalog No.
J863) with a slight modification for induction. Induction in M9
included 1 mM IPTG and supplementation with 1 mM FeCl2,
1 mM ZnCl2 or 1 mM MnCl2. The cells were recovered by
centrifugation at 4500g for 30 min at 4C. The cell pellets were
resuspended in ice-cold lysis buffer consisting of 20 mM Tris
pH 7.6, 50 mM NaCl, 20 mM imidazole, 0.05%(w/v) NaN3
with protease-inhibitor cocktail (cOmplete EDTA-free
Protease Inhibitor Cocktail, Roche; catalog No. 05056489001)
and were stored at 80C. After thawing the suspension, the
cells were lysed by three cycles in a French press at 10.3 MPa.
The crude extract was centrifuged at 48 000g for 20 min at 4C
to recover the cell lysate. The lysate supernatant was syringe-
filtered using a 0.45 mm membrane unit (Millex; catalog No.
SLHV013SL) and subsequently loaded onto a 5 ml HisTrap
HP column (GE Healthcare Life Sciences; catalog No.
17-5248-02) that had been pre-equilibrated in lysis buffer. The
loaded column was washed with lysis buffer until a stable
baseline was achieved and YfeA-His10 was eluted with a linear
gradient of 0.02–1 M imidazole over ten column volumes.
Fractions containing YfeA-His10 were pooled, buffer-
exchanged into ion-exchange buffer consisting of 20 mM Tris
pH 7.6, 0.05%(w/v) NaN3 and loaded onto a 5 ml HiTrap Q
HP column (GE Healthcare Life Sciences; catalog No.
17-1154-01) that had been pre-equilibrated in ion-exchange
buffer. The loaded column was washed with ion-exchange
buffer until a stable baseline was achieved and YfeA-His10 was
eluted with a linear gradient of 0–1 M NaCl over ten column
volumes. Fractions containing YfeA-His10 were pooled,
concentrated in a stirred cell (Amicon; catalog No.
UFSC05001) using a 10 kDa molecular-weight cutoff
membrane (Millipore; catalog No. PLGC04310) until the
volume reached 5 ml and loaded onto a HiLoad 26/600
Superdex 200 pg column (GE Healthcare Life Sciences;
catalog No. 28-9893-36) that had been pre-equilibrated in gel-
filtration buffer consisting of 20 mM bis-tris pH 6.3, 50 mM
NaCl, 0.05%(w/v) NaN3. Each purification step was monitored
by SDS–PAGE (Fig. 2). The final purified YfeA-His10 product
in gel-filtration buffer was concentrated in a centrifugal filter
unit (Amicon; catalog No. UFC901024) to a final concentra-
tion of 18  5 mg ml1 for crystallization. In EDTA experi-
ments, 2 mM EDTA was added to the ion-exchange and
gel-filtration chromatography buffers, and the purified protein
was dialyzed overnight against 100 mM EDTA prior to
protein concentration and crystallization.
2.2. Cloning, overexpression and purification of native YfeA
in the context of YfeBCDE
The previously described pYFE3 plasmid (Bearden et al.,
1998; Bearden & Perry, 1999) containing the entire YfeA–E
locus was transformed into E. coli strain BL21-CodonPlus
(DE3)-RIPL competent cells (Agilent Technologies; catalog
No. 230280). The transformed cells were grown in M9 minimal
medium (Amresco; catalog No. J863) containing 50 mg ml1
ampicillin with shaking at 225 rev min1 at 37C for 9 h. The
cells were recovered by centrifugation at 4500g for 30 min at
4C. The cell pellets were resuspended in ice-cold lysis buffer
consisting of 20 mM phosphate buffer pH 7.6, 50 mM NaCl
and were stored at 80C. After thawing the suspension, the
cells were centrifuged at 4000g for 20 min at 4C and then
resuspended in 0.2 M Tris pH 8.0, 0.4 M NaCl, 2 mM EDTA to
begin cell fractionation. The cells were incubated over ice for
20 min with occasional inversion to counter sedimentation.
The cells were then re-centrifuged at 4000g for 20 min at 4C,
resuspended in 10 mM Tris pH 8.0 and incubated over ice for
an additional 20 min with occasional inversion to counter
sedimentation. Spheroplasts were pelleted by centrifugation
at 48 000g for 20 min at 4C and the periplasmic fraction was
recovered from the supernatant. The spheroplasts were
resuspended in 20 mM phosphate buffer pH 7.6, 50 mM NaCl
and lysed by three cycles in a French press at 10.3 MPa. The
crude extract was centrifuged at 48 000g for 20 min at 4C to
recover the cell-lysate supernatant. The membranes were
separated from the lysate supernatant by centrifugation at
70 000g for 45 min at 4C and the cytoplasmic fraction was
recovered from the supernatant. The pellet was then resus-
pended in 4%(v/v) Triton X-100 and mixed by gentle rocking
overnight at 4C. The mixture was then centrifuged at 70 000g
for 45 min at 4C, and the inner membrane fraction was
recovered from the supernatant. The pellet containing the
outer membrane fraction was then resuspended in 0.1%(w/v)
DDM. Immediately after extraction, the periplasmic fraction
was syringe-filtered using a 0.45 mm membrane unit (Millex;
catalog No. SLHV013SL) and subsequently loaded onto a
5 ml HiTrap Q HP column (GE Healthcare Life Sciences;
catalog No. 17-1154-01) that had been pre-equilibrated in ion-
exchange buffer. The loaded column was washed with ion-
exchange buffer until a stable baseline was achieved and
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native YfeA was eluted with a linear gradient of 0–1 M NaCl
over ten column volumes. The remainder of the purification
from this point was identical to that for YfeA-H10.
2.3. Mass-spectrometry data collection
The stained bands were excised and the stain was removed
by an overnight wash in 50% 100 mM ammonium bicarbo-
nate/50% acetonitrile. Disulfide bonds were reduced using
25 mM dithiothreitol at 50C for 30 min followed by alkylation
of the free thiol groups with 55 mM iodoacetamide for 30 min
in the dark. After the removal of excess alkylating agent, the
gel pieces were evaporated to dryness prior to reswelling in
100 mM ammonium bicarbonate buffer and overnight diges-
tion using mass-spectrometry-grade trypsin (12.5 ng ml1).
Tryptic peptides were extracted using a solution of 1% formic
acid in water and acetonitrile (50:50) and then evaporated to
dryness in a Speedvac. The samples were resuspended in 30 ml
double-distilled water (ddH2O) with 0.1% formic acid for
mass-spectrometric evaluation.
An aliquot (5 ml) of each digest was loaded onto a Nano
cHiPLC (200 mm  0.5 mm, ChromXP C18-CL, 3 mm, 120 Å)
reverse-phase trap cartridge (Eksigent, Dublin, California,
USA) at 2 ml min1 using an Eksigent 415 LC system auto-
sampler. After washing the cartridge for 10 min with 0.1%
formic acid in ddH2O, the bound peptides were flushed onto a
Nano cHiPLC column (200 mm internal diameter  15 cm,
ChromXP-C18-CL, particle size 3 mm, pore size 120 Å;
Eksigent, Dublin, California, USA) with a 15 min linear (5–
50%) acetonitrile gradient in 0.1% formic acid at
1000 nl min1 using an Eksigent Nano1D+LC (Dublin,
California, USA). The column was washed with 95% aceto-
nitrile/0.1% formic acid for 5 min and then re-equilibrated
with 5% acetonitrile/0.1% formic acid for 5 min. A SCIEX
5600 Triple-TOF mass spectrometer (Sciex, Toronto, Canada)
was used to analyze the protein digest. The ion-spray voltage
research papers
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Figure 2
Purification and crystallization of YfeA. (a) SDS–PAGE gel showing the enrichment of YfeA during the various steps of purification. Molecular-weight
standards are shown on the left (labeled in kDa). Lane 1, uninduced BL21 whole cells. Lane 2, BL21 whole cells induced with IPTG. Lane 3, lysate
supernatant fraction following cell disruption with a French press. Lane 4, eluate from nickel-affinity chromatography. Lane 5, eluate from anion-
exchange chromatography. Lane 6, gel-filtration peak fraction. (b) Superdex 200 10/300 GL gel-filtration chromatogram from YfeA purification.
Fractions containing the peak from this chromatogram were concentrated, are represented in lane 6 in (a) and were used for crystallography. (c)
Representative images of YfeA crystals.
was 2300 V and the declustering potential was 80 V. The ion-
spray and curtain gases were set at 69 and 172 kPa, respec-
tively. The interface heater temperature was 120C. The eluted
peptides were subjected to a time-of-flight survey scan from m/
z 400 to 1250 to determine the top 20 most intense ions for
MS/MS analysis. Product-ion time-of-flight scans at 50 ms
were carried out to obtain the tandem mass spectra of the
selected parent ions over the m/z range 400–1500. Spectra
were centroided and de-isotoped by the Analyst software v.1.6
TF (Sciex). A -galactosidase trypsin digest was used to
establish and confirm the mass accuracy of the mass spectro-
meter.
The tandem mass-spectrometry data were processed to
provide protein identification in-house using the Protein Pilot
4.5 search engine (Sciex) using the Y. pestis UniProt protein
database and using a trypsin-digestion parameter. Proteins of
significance were accepted on the criteria of having at least
two peptides detected with a confidence score of 95% or
greater.
2.4. YfeA crystallization
Crystallization conditions were determined by a rational
approach comparing the crystallization conditions of YfeA
orthologs in the Protein Data Bank (PDB). YfeA-His10 and
native YfeA protein crystals were grown by the hanging-drop
and sitting-drop vapor-diffusion methods at 293 K in gel-
filtration buffer with 30–40%(w/v) PEG 4000. The final,
optimized condition that led to the highest resolution data set
was 20 mM bis-tris pH 6.3, 50 mM NaCl, 0.05%(w/v) NaN3,
30%(w/v) PEG 4000. Drops consisted of YfeA-His10 or native
YfeA plus reservoir solution in 1:1, 1:2 and 2:1 ratios for
hanging-drop setup. Crystals grew in two main morphologies,
tetragonal prisms and thin plates, and were directly flash-
cooled in liquid nitrogen. Co-crystallization experiments
included the addition of 10 mM ZnCl2, 10 mM MnCl2 or
10 mM FeCl2 and 1 mM -mercaptoethanol to the crystal-
lization-drop solution. The final, optimized condition that
produced the crystals used for anomalous data collection and
led to the confirmation of site 2 was 20 mM bis-tris pH 6.3,
50 mM NaCl, 0.05%(w/v) NaN3, 32%(w/v) PEG 4000. In the
EDTA experiments, purified YfeA-His10 protein was co-
incubated with 2 mM EDTA in 20 mM bis-tris pH 6.3, 50 mM
NaCl, 0.05%(w/v) NaN3, 35%(w/v) PEG 4000. Soaking
experiments with YfeA-H10 included 3 and 4 h soaks in
10 mM ZnCl2, 10 mM MnCl2 or 10 mM FeCl2 + 1 mM
-mercaptoethanol. Some crystals changed from clear to
yellow during soaking.
2.5. X-ray data collection, structure solution and refinement
Diffraction data were collected at 100 K on the Southeast
Regional Collaborative Access Team (SER-CAT) 22-ID
beamline and the General Medical Sciences and Cancer
research papers
Acta Cryst. (2017). D73, 557–572 Radka et al.  Yersinia pestis virulence factor YfeA 561
Figure 3
Overall structure of YfeA. YfeA is a c-clamp. The structure contains two globular lobe domains that are interconnected by an -helical backbone. The
position of the site 1-bound metal is shown. Surface rendering shows that site 1 is deeply buried in the c-clamp.
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Table 1
Data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
YfeA (Zn) EDTA (Zn) Site 2 (Zn) Site 2 (Mn)
Apo site 2,
ancillary sites (Zn)
Bound site 2,
ancillary sites (Zn)
PDB code 5uxs 5uxu 5uyg 5uyh 5uyv 5uyw
Data collection
Beamline SER-CAT, APS GM-CA, APS SER-CAT, APS SER-CAT, APS GM-CA, APS SER-CAT, APS
Wavelength (Å) 1.28281 1.28229 1.28281 1.89288 1.27932 1.28281
Space group P212121 P212121 P212121 P212121 P212121 P212121
a, b, c (Å) 41.74, 52.12,
113.07
55.32, 66.88,
81.69
62.36, 66.04,
66.83
62.39, 66.10,
66.83
41.52, 51.96,
112.75
62.28, 66.36,
67.09
 =  =  () 90 90 90 90 90 90
VM† (Å
3 Da1) 1.98 2.43 2.21 2.21 1.95 2.23
Solvent content (%) 37.77 49.36 44.38 44.46 37.07 44.80
Resolution (Å) 50.00–1.42
(1.44–1.42)
50.00–1.84
(1.87–1.84)
50.00–1.86
(1.89–1.86)
50.00–1.99
(2.02–1.99)
50.00–1.69
(1.72–1.69)
50.00–1.95
(1.98–1.95)
Unique reflections 47252 (2340) 26517 (1199) 23851 (1183) 19483 (940) 27201 (1217) 20672 (998)
Completeness (%) 99.7 (99.6) 98.0 (90.6) 99.8 (99.9) 99.3 (96.9) 96.8 (88.4) 99.6 (98.4)
Multiplicity 4.6 (4.5) 3.3 (2.6) 4.8 (4.8) 4.6 (4.0) 3.2 (2.7) 4.8 (4.8)
CC1/2 98.1 (85.4) 99.5 (92.4) 98.6 (90.3) 99.5 (83.3) 94.8 (75.2) 99.6 (97.4)
Rmerge (%) 9.8 (40.1) 6.6 (17.1) 7.1 (33.5) 6.4 (40.3) 8.2 (25.9) 7.1 (42.1)
Rmeas (%) 11.1 (45.6) 7.9 (21.1) 8.0 (42.6) 7.2 (46.2) 9.7 (32.1) 8.0 (47.1)
Rp.i.m. (%) 5.1 (21.3) 4.2 (12.2) 3.5 (18.8) 3.2 (22.2) 5.2 (18.6) 3.6 (20.7)
Mean I/(I) 52.8 (2.2) 48.9 (0.5) 46.6 (0.4) 53.6 (0.4) 43.7 (4.1) 44.9 (0.7)
Refinement
Resolution (Å) 33.58–1.42
(1.44–1.42)
40.86–1.84
(1.86–1.84)
46.99–1.86
(1.88–1.86)
47.01–1.99
(2.02–1.99)
38.97–1.69
(1.71–1.69)
31.14–1.95
(1.98–1.95)
No. of non-anomalous reflections 47185 26477 23804 19437 27168 20628
Completeness (%) 99.4 (97.0) 94.5 (81.1) 99.9 (99.1) 99.2 (96.4) 90.8 (77.6) 99.5 (94.7)
Rwork (%) 17.88 (25.64) 17.03 (23.63) 18.92 (24.74) 18.56 (31.23) 17.31 (27.62) 18.66 (26.28)
Rfree‡ (%) 19.03 (29.52) 20.30 (23.16) 21.80 (29.36) 23.53 (30.36) 20.61 (34.63) 22.39 (32.42)
Wilson B factor (Å2) 15.596 19.045 28.509 36.649 17.145 27.528
Average B factor (Å2) 21.99 22.57 35.44 41.59 19.86 35.52
No. of protein atoms 2153 2161 2140 2159 2154 2140
Solvent atoms 365 H2O, 1 Zn 404 H2O, 1 Zn 250 H2O, 2 Zn 179 H2O, 2 Mn 363 H2O, 6 Zn 188 H2O, 6 Zn
No. of molecules in ASU§ 1 1 1 1 1 1
R.m.s.d.}, bond lengths (Å) 0.006 0.007 0.008 0.008 0.007 0.008
R.m.s.d., bond angles () 0.76 0.875 0.887 0.894 0.841 0.907
Ramachandran plot
Favored (%) 97.06 97.8 96.67 97.78 96.69 95.56
Allowed (%) 2.21 1.47 2.96 2.22 2.57 3.7
Outliers (%) 0.74 0.73 0.37 0 0.74 0.74
Clashscore 2.79 3.24 7.47 5.37 4.87 7.46
MolProbity score 1.23 1.16 1.62 1.34 1.46 1.72
† Matthews coefficient. ‡ The test set uses 5% of the data. § Asymmetric unit. } Root-mean-square deviation.
Figure 4
YfeA model fit. Model overlay of anomalous electron density contoured at 5 (magenta mesh) with 2Fo  Fc electron density (blue mesh) at site 1. The
enlarged images at a proline and aromatic residues show the map quality, highlighting apparent holes in ringed structures.
Institutes Structural Biology Facility (GM/CA) 23-ID-B and
23-ID-D beamlines at the Advanced Photon Source (APS),
Argonne National Laboratory, and the Canadian Macro-
molecular Crystallography Facility (CMCF) 08ID-1 beamline
at the Canadian Light Source (CLS), University of Saskatch-
ewan. The anomalous X-ray scattering K-edge energies for
Zn, Mn and Fe were empirically determined for each data
collection. The data-collection strategy for each crystal was
determined using the iMosflm Strategy function (Battye et al.,
2011), targeting 95% completeness for anomalous data.
Energy-dispersive X-ray spectroscopy fluorescence data were
collected at 100 K at the General Medical Sciences and Cancer
Institutes Structural Biology Facility (GM/CA) 23-ID-B and
23-ID-D beamlines at the Advanced Photon Source, Argonne
National Laboratory. The data were merged and scaled using
HKL-2000 (Otwinowski & Minor, 1997). The data complete-
ness and Rmerge were used to determine the resolution limit.
Phases were determined by SAD using AutoSol as imple-
mented in the PHENIX suite (Adams et al., 2010). Model
building and refinement were performed using AutoBuild and
PHENIX. In the case of building models of YfeA molecules
with Zn atoms bound to ancillary surface sites, the grouping of
ancillary sites that did not co-load with site 2 contained two Zn
atoms that shifted slightly out of anomalous density during
refinement. Occupancy and/or anomalous refinement did not
improve their final locations, so we set the occupancies of
these atoms to 1.00 and manually moved them back into
anomalous density for the final PDB file. The figures were
generated using PyMOL (http://www.pymol.org).
2.6. Sequence alignment
YfeA orthologs were identified by searching the YfeA
primary structure against the PDB (Berman et al., 2000).
research papers
Acta Cryst. (2017). D73, 557–572 Radka et al.  Yersinia pestis virulence factor YfeA 563
Table 2
Data-collection and refinement statistics.
Values in parentheses are for highest resolution shell.
M9–Fe
(Zn)
M9–Fe
(Fe)
M9–Fe
(Mn)
M9–Mn
(Zn)
M9–Mn
(Fe)
M9–Mn
(Mn)
M9–Zn
(Zn)
M9–Zn
(Fe)
M9–Zn
(Mn)
PDB code 5uy0 5uy4 5uy5 5uya 5uyb 5uyc 5uyd 5uye 5uyf
Data collection
Beamline CMCF, CLS CMCF, CLS CMCF, CLS CMCF, CLS CMCF, CLS CMCF, CLS CMCF, CLS CMCF, CLS CMCF, CLS
Wavelength (A) 1.28215 1.74013 1.89174 1.28215 1.74013 1.89289 1.28215 1.74013 1.89289
Space group P212121 P212121 P212121 P212121 P212121 P212121 P212121 P212121 P212121
a, b, c (Å) 61.93, 66.47,
67.25
61.93, 66.37,
67.15
61.97, 66.49,
67.21
41.79, 52.13,
113.01
41.75, 52.19,
112.75
41.73, 52.18,
112.78
41.79, 52.17,
112.80
41.81, 52.17,
112.77
41.86, 52.19,
112.77
 =  =  () 90 90 90 90 90 90 90 90 90
VM† (Å
3 Da1) 2.22 2.22 2.23 1.98 1.97 1.97 1.98 1.98 1.98
Solvent content (%) 44.71 44.54 44.73 37.83 37.69 37.67 37.76 37.77 37.87
Resolution (Å) 50.00–1.71
(1.74–1.71)
50.00–1.92
(1.95–1.92)
50.00–2.15
(2.19–2.15)
50.00–1.72
(1.75–1.72)
50.00–1.95
(1.98–1.95)
50.00–1.96
(1.99–1.96)
50.00–1.93
(1.96–1.93)
50.00–2.09
(2.13–2.09)
50.00–2.06
(2.10–2.06)
Unique reflections 30412 (1478) 21484 (1046) 15410 (654) 26994 (1320) 18617 (921) 18167 (784) 19305 (937) 15274 (713) 15986 (800)
Completeness (%) 98.9 (97.7) 98.0 (96.1) 97.5 (85.4) 99.8 (98.7) 99.7 (99.9) 98.9 (88.3) 99.9 (99.9) 99.9 (99.9) 99.9 (99.9)
Multiplicity 8.1 (8.1) 7.9 (7.8) 7.8 (6.5) 7.4 (7.3) 7.6 (7.5) 7.3 (4.3) 7.2 (7.2) 7.3 (7.4) 7.2 (6.9)
CC1/2 99.7 (93.8) 99.7 (93.4) 99.7 (95.4) 99.5 (96.5) 99.5 (94.1) 99.6 (74.7) 99.5 (93.7) 99.5 (94.1) 99.5 (88.3)
Rmerge (%) 8.5 (40.4) 6.3 (41.4) 6.5 (24.0) 9.6 (40.4) 9.2 (40.2) 9.4 (37.9) 9.6 (42.6) 9.4 (41.8) 9.3 (41.1)
Rmeas (%) 9.0 (43.1) 6.8 (44.3) 7.0 (26.1) 10.3 (43.3) 9.8 (43.3) 10.1 (43.5) 10.3 (45.9) 10.2 (44.9) 10.0 (44.6)
Rp.i.m. (%) 3.2 (15.0) 2.4 (15.5) 2.5 (9.9) 3.7 (15.4) 3.5 (15.8) 3.6 (20.8) 3.8 (16.9) 3.7 (16.4) 3.7 (17.1)
Mean I/(I) 56.0 (1.4) 56.0 (3.1) 67.4 (14.0) 59.1 (7.9) 52.7 (5.2) 73.2 (13.3) 54.8 (6.4) 51.3 (6.0) 67.3 (13.5)
Refinement
Resolution (Å) 30.97–1.71
(1.73–1.71)
47.22–1.92
(1.94–1.92)
37.59–2.14
(2.18–2.14)
38.32–1.72
(1.74–1.72)
39.16–1.95
(1.98–1.95)
38.29–1.96
(1.99–1.96)
39.19–1.92
(1.95–1.92)
39.21–2.09
(2.12–2.09)
38.30–2.06
(2.09–2.06)
No. of non-anomalous
reflections
30366 21444 15376 26936 21444 18116 19252 15227 15934
Completeness (%) 98.9 (96.5) 97.8 (89.4) 97.6 (82.8) 99.5 (93.9) 99.5 (96.6) 98.6 (82.8) 99.7 (91.9) 99.9 (97.1) 99.6 (92.5)
Rwork (%) 17.85 (23.69) 17.28 (29.27) 16.34 (18.19) 16.45 (18.40) 16.51 (23.26) 16.83 (29.84) 16.19 (22.62) 16.18 (19.11) 16.24 (22.29)
Rfree‡ (%) 21.24 (23.13) 20.14 (32.99) 20.40 (23.83) 19.22 (21.57) 20.17 (30.77) 20.29 (33.45) 20.11 (28.45) 20.68 (26.04) 20.04 (23.20)
Wilson B factor (Å2) 27.603 27.43 33.109 20.66 22.293 26.003 22.727 26.184 34.315
Average B factor (Å2) 33.14 32.52 37.75 24.92 26.66 29.43 25.87 29 37.06
No. of protein atoms 2133 2133 2133 2153 2133 2153 2153 2153 2153
Solvent atoms 285 H2O,
1 Zn
245 H2O,
1 Fe
180 H2O,
1 Mn
293 H2O,
1 Zn
245 H2O,
1 Fe
229 H2O,
1 Mn
284 H2O,
1 Zn
211 H2O,
1 Fe
181 H2O,
1 Mn
No. of molecules in ASU§ 1 1 1 1 1 1 1 1 1
R.m.s.d.}, bond lengths (Å) 0.007 0.007 0.008 0.006 0.006 0.007 0.007 0.007 0.006
R.m.s.d.}, bond angles () 0.808 0.805 0.832 0.775 0.764 0.799 0.774 0.804 0.766
Ramachandran plot
Favored (%) 98.14 98.14 98.51 96.69 98.14 96.69 96.32 96.69 97.06
Allowed (%) 1.86 1.86 1.49 2.21 1.86 2.57 2.94 2.57 2.21
Outliers (%) 0 0 0 1.1 0 0.74 0.74 0.74 0.74
Clashscore 5.39 4.45 4.92 4.18 4.41 5.11 3.71 4.41 2.55
MolProbity score 1.29 1.22 1.26 1.41 1.39 1.48 1.41 1.43 1.21
† Matthews coefficient. ‡ The test set uses 5% of the data. § Asymmetric unit. } Root-mean-square deviation.
Sequence alignment of YfeA with orthologs was performed
using Clustal Omega at http://www.ebi.ac.uk/Tools/msa/
clustalo/.
3. Results
3.1. YfeA utilizes a c-clamp architecture
YfeA (YfeA-H10) was isolated to apparent purity (>99%)
and homogeneity by nickel-affinity, anion-exchange and gel-
filtration chromatography (Fig. 2b). YfeA migrates as a single
30 kDa band on an SDS–PAGE gel (Fig. 2a). Diffraction-
quality crystals were grown by the optimization of initial hits
that were identified by rational screening (Fig. 2c), and the
Bravais lattice belonged to the orthorhombic crystal system
P212121. By varying the protein-expression conditions, we
observed crystallization of YfeA in three crystal forms. In this
report, the lattices with edges 42 52 113, 62 66 67 and
55  67  82 Å will be referred to as crystal forms 1, 2 and 3,
respectively. The structure of crystal form 1 was solved by
single anomalous dispersion (SAD), and the structures in the
other crystal forms were determined by molecular replace-
ment (MR). 80% of all residues in crystal form 1 were built
using AutoBuild in PHENIX, and the generated model was
refined to an Rwork and Rfree of 17.88 and 19.03%, respectively,
and used for MR and refinement of crystal form 2 and crystal
form 3 (Adams et al., 2010). The high-quality diffraction data
enabled the resolution of holes in aromatic and proline
residues (Fig. 3). Strong anomalous data collected at the
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Figure 5
Primary-structure alignment of YfeA ortholog SBPs. YfeA, designated as Yersinia, aligned with orthologs from other genera, including Gram-positive
genera, with known three-dimensional structures: Salmonella enterica zinc-binding protein ZnuA (PDB entry 2xy4; Ilari et al., 2014), Bacillus subtilis
manganese-binding protein YcdH (PDB entry 2o1e; Northeast Structural Genomics Consortium, unpublished work), Treponema pallidum zinc-binding
protein TroA (PDB entry 1toa; Lee et al., 1999), Paracoccus denitrificans zinc-binding protein Pden1597 (PDB entry 4xrv; Handali et al., 2015),
Staphylococcus aureus manganese-binding protein MntC (PDB entry 4k3v; Gribenko et al., 2013), Streptococcus pneumoniae manganese-binding protein
PsaA (PDB entry 3ztt; McDevitt et al., 2011), Listeria monocytogenes manganese-binding protein MntA (PDB entry 5i4k; Center for Structural
Genomics of Infectious Diseases, unpublished work), Candidatus Liberibacter asiaticus manganese-binding protein CLas-ZnuA2 (PDB entry 4cl2;
Sharma et al., 2015) and Synechocystis sp. PCC 6803 manganese-binding protein MntC (PDB entry 1xvl; Rukhman et al., 2005). Site 1 ligands from all
orthologs are shown in yellow. Site 2 in YfeA is shown in dark blue. Tertiary, ancillary sites that co-load with site 2 are shown in purple, and sites that do
not co-load with site 2 are shown in light blue.
Zn K-shell electron energy absorption edge (K edge) clearly
identified the canonical site in YfeA (Fig. 4). Data statistics
are provided in Tables 1 and 2.
In all crystal forms, YfeA is a c-clamp with amino-terminal
and carboxy-terminal / globular domains that are
connected by an -helical backbone linking region (Fig. 3).
Each / domain–backbone interface is distinguishable by
-strand hinges that are similar to those in other SBPs. At the
arch of the c-clamp is a tetracoordinate canonical site
composed of His76, His141, Glu207 and Asp282. These resi-
dues are in alignment agreement with other SBPs of known
structure from Gram-positive and Gram-negative genera
(Fig. 5). This canonical metal-binding site is the primary metal-
binding site in YfeA and we refer to it as site 1.
3.2. YfeA is a polyspecific SBP and site 1 metal occupancy
depends on environmental conditions
The EDS spectra of YfeA crystals from protein purified
from E. coli cells grown in Luria–Bertani broth (LB) revealed
strong florescence emission signals from zinc and weak signals
from iron and manganese (Fig. 6). Although this observation
suggests that the primary ligand at site 1 is zinc, further
inspection was needed as nutrient-rich conditions contain
unequal abundances of free metals in solution, and zinc is the
most abundant transition metal in LB (Outten & O’Halloran,
2001). To better probe the site 1 metal preference, YfeA
protein was purified from E. coli cells grown in M9 minimal
medium (M9) that was supplemented with either zinc,
manganese or iron in separate experiments during YfeA
overexpression. Minimal medium was used in many of the
experiments in this study because minimal medium constrains
cells to maintain tighter regulation over cellular processes
compared with cells growing in LB, thereby enabling the
observation of relevant cellular processes that may otherwise
be masked by cellular physiology. By design, metal supple-
mentation ensured that whichever metal was added became
the most abundant metal in solution and was available for
YfeA chelation. Surprisingly, under these conditions the
strongest fluorescence emission from YfeA crystals was still
from zinc, although as expected the greatest disparity between
the zinc signal and the iron or manganese signal occurred from
M9 with zinc supplementation (Fig. 6). M9 iron supple-
mentation caused a threefold increase in iron emission relative
to the iron signal from nutrient-rich conditions (Fig. 6). M9
manganese supplementation caused a fivefold increase in
manganese emission relative to the manganese signal from
nutrient-rich conditions (Fig. 6). 1 mM MnCl2 was used for
manganese supplementation instead of the 1 mM metal
concentration that was used in the M9 zinc and iron experi-
ments because higher levels of manganese inhibited cell
growth and reduced the biomass prior to protein purification.
1 mM MnCl2 was determined to be an acceptable compromise
between final biomass and metal supplementation. Granted,
1 mM MnCl2 is still tenfold greater than the manganese level in
LB (Outten & O’Halloran, 2001). ANOVA statistical testing
indicates that the changes in manganese and iron emission
signals from their respective M9 experiments are statistically
relevant, with the iron change yielding a p value of 2.6  104
at  = 0.01 and the manganese change yielding a p value of
7.9  106 at  = 0.01. Although zinc emission always
produced the strongest signal of the metals, it is evident from
EDS that changes in the growth conditions elicit changes in
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Figure 7
Anomalous electron density at site 1. Enlarged images of the structural model at site 1 with an overlay of anomalous electron density (magenta mesh)
with 2Fo  Fc electron density (blue mesh). In all maps, the anomalous density is contoured at 5 to emphasize the differences in signal for manganese
(a), iron (b) and zinc (c). In (a) and (b) there is additional anomalous density from a methionine S atom that does not appear for the same S atom in the
zinc data. These images were collected using data from the M9–Zn experiment.
Figure 6
EDS spectra of YfeA crystals. The EDS data show changes in the metal
signal profiles according to cell-growth conditions. Data are represented
as the mean  1. Asterisks indicate changes that are statistically
significant. In M9 iron experiments, the change in iron had a calculated p
value of 2.6  104 with  = 0.01. In M9 manganese experiments, the
change in manganese had a calculated p value of 7.9 106 with  = 0.01.
Zinc remains the dominant substrate in native, untagged YfeA that is
overexpressed in the context of YfeBCDE and purified from the
periplasm.
the relative abundance of metals in YfeA. To show that these
changes correlate with metal incorporation at site 1, anom-
alous X-ray scattering data were collected at the zinc, iron and
manganese K edges from crystals grown from M9 experiments
(Fig. 7). By collecting X-ray data at the various K edges, the
anomalous contribution from each metal provided another
quantitative tool to precisely evaluate the ligand bound to site
1. Additionally, the structural data confirmed that the only
ordered metal that could contribute anomalous signal was
bound to site 1, and given that YfeA substrates were absent
from purification buffers and crystallization conditions, the
metal bound to site 1 must have been sequestered by YfeA in
vivo. In the anomalous X-ray data, the strongest signal at site 1
is from zinc (Fig. 7a), but there is positive signal for iron (Fig.
7b) and manganese (Fig. 7c). The anomalous signals for each
metal increased during their respective M9 experiments and
are in good agreement with the EDS data. As an internal
control for energy changes to longer wavelengths (1.28 Å for
zinc,1.74 Å for iron and1.89 Å for manganese), an S atom
from Met144 is visible, contributing a positive weak anom-
alous signal, shown as pink mesh, that intensified as the
experimental wavelength approached the anomalous sulfur
edge (Figs. 7a, 7b and 7c). Elsewhere in the model, an addi-
tional S atom from Met99 was also observed to contribute a
positive weak anomalous signal at longer wavelengths. Across
all conditions and crystals tested in this study, fluorescence
experiments were only positive for zinc, manganese and iron,
and were negative for all other metals, including divalent
species. Taken together, the EDS and anomalous X-ray scat-
tering data show that site 1 is predominantly loaded with zinc
but can incorporate manganese
or iron under nutrient-limiting
conditions in vivo. The inter-
atomic distances of site 1 ligands
are 3.0 Å 	 x–x1 	 3.6 Å. In
proteins, the mean interatomic
distances from ligand to zinc, iron
and manganese are 2.27, 2.64 and
2.23 Å, respectively (Goyal &
Mande, 2008). Additionally, zinc,
iron and manganese can bind
with tetracoordinate geometry
(Lide, 2001). Based on this
analysis, the interatomic distances
of site 1 ligands can integrate
zinc, iron and manganese, further
supporting the hypothesis that
YfeA site 1 is polyspecific.
Control EDS experiments with
YfeA protein exposed to EDTA,
in which any metals bound to the
His10 tag would be removed,
determined that nonspecific
metal binding to the tag cannot
have influenced the EDS signa-
tures of zinc, manganese or iron
binding.
3.3. Without YfeBCDE, YfeA site 1 is always occupied in
E. coli and cannot be stripped by EDTA
YfeA homologs have previously been produced in the apo
state by dialyzing purified protein against EDTA prior to
crystallization (Yatsunyk et al., 2008; Abate et al., 2014;
Sharma et al., 2015). EDTA was similarly used in this work to
attempt to generate apo YfeA protein. Initial dialysis against
10 mM EDTA did not remove the metal from site 1; therefore,
2 mM EDTA was added to the anion-exchange and gel-
filtration buffers and 100 mM EDTA was used for overnight
dialysis. The X-ray data showed that site 1 was still occupied
after this treatment; hence, we sought co-crystallization with
1 mM EDTA. EDTA co-crystallization also did not strip the
metal from site 1; however, these studies uncovered crystal
form 3 and indicated that site 1 is deeply buried (Fig. 3). For
YfeA to surrender its metal, a significant conformational
change, unfolding, proteolytic or other enzymatic event
appears to be essential. The observation that site 1 is always
metal-bound suggests that either YfeA spontaneously
scavenges metal or, albeit unlikely, requires a binding partner
for metal loading that is also present in E. coli. Although site 1
is always metal-bound in our studies, we do not exclude the
possibility of an E. coli mechanism that may unload site 1 in
vivo.
3.4. YfeA has a secondary polyspecific metal-binding site
Prior to realising that site 1 is always occupied, YfeA co-
crystallization experiments with zinc, iron or manganese were
conducted to attempt to influence metal incorporation into
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Figure 8
Polyspecificity at site 2 and additional metal-binding sites in YfeA. (a, b) Enlarged images of the structural
model at site 2 with an overlay of anomalous electron density (magenta mesh) with 2Fo  Fc electron
density (blue mesh). In both maps, the anomalous density is contoured at 5 to show the differences in
signal for manganese (a) and zinc (b). Water molecules are shown as red spheres, and manganese and zinc
ions are shown as spheres colored by CPK chemical convention. (c, d) Cartoon representation of all metal-
binding sites in YfeA with an overlay of anomalous electron density (magenta mesh) contoured at 5. (c)
Ancillary sites that do no co-load with site 2. (d) Ancillary sites that co-load with site 2.
site 1. Although co-crystallization did not have any impact on
site 1, the experimental outcomes were unique to each metal.
Co-crystallization experiments with iron and -mercapto-
ethanol [used to maintain iron(II) oxidation in the crystal-
lization drop] resulted in clear drops that never produced
crystals, while zinc co-crystallization experiments resulted in
immediate heavy precipitation. Manganese co-crystallization
experiments produced diffraction-quality crystals which, after
anomalous X-ray data processing, revealed a secondary metal-
binding site referred to in this manuscript as site 2. After
further investigation, site 2 was determined to be polyspecific
and capable of binding manganese and zinc. In an experi-
mental set of >40 YfeA crystals, site 2 was never observed to
be metal-bound unless manganese was included in the co-
crystallization experiment but, curiously, zinc is the preferred
metal for site 2. This observation was initially peculiar, as it
suggested that site 2 was highly specific for zinc and was able
to bind contaminating zinc ions from the MnCl2 reagent while
also binding manganese. Furthermore, the anomalous signal
was always stronger from zinc than manganese at site 2, and
could not be manipulated otherwise. Site 2 is a surface site
made up of the ligands Glu162 and His163, with ordered water
molecules filling the vacant orbitals of bound metal ions
(Figs. 8a and 8b). Soaking YfeA crystals in manganese or zinc
could not load site 2, and multiple trials of consecutive back-
soaking experiments in crystallization buffer void of
manganese or zinc could not remove metal from site 2.
Co-crystallization and back-soaking experiments indicate that
the loading of site 2 is only observable through crystallization,
which irreversibly traps metal bound to site 2 and precludes
exogenous metal from binding in site 2. Soaking experiments
indicate that site 2 ligands may require conformational flex-
ibility for metal loading, which is
only available while YfeA is still
in a monomeric form in solution
prior to the impasse imposed by
crystallization.
Should site 2 be loaded in vivo,
we expect the bound metal to be
readily exchangeable and to play
a role in communication with the
Yfe transporter and/or direct
metal transport. To provide an
additional line of evidence that
zinc was bound at site 2, albeit as
a MnCl2 chemical contaminant, a
zinc–manganese co-crystallization
titration experiment was
performed to determine a zinc
concentration that would not
precipitate YfeA and still produce
crystals, as well as increase the
zinc occupancy at site 2. The
maximum concentration of zinc
that produced crystals with
metal bound to site 2 was 10 mM
ZnCl2/1 mM MnCl2. Co-titration
increased the difference between
the amount of zinc loaded at site 2
relative to manganese, making
zinc, which was already favored at
site 2 in the original experiment,
even more represented than
before. The co-titration experi-
ment also suggests that mangan-
ese influences the YfeA structure
in a way that cannot be detected
crystallographically. A zinc titra-
tion was performed in the absence
of manganese at a lower concen-
tration range to avoid YfeA
precipitation, but the crystals that
grew did not have any metal
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Figure 9
Fractionation of E. coli cells overexpressing the Yfe locus by an endogenous promoter. (a) SDS–PAGE gel
showing expression of Yfe locus components and localization of YfeA in the E. coli BL21-CodonPlus
(DE3)-RIPL periplasm. Molecular-weight standards are shown on the left (labeled in kDa). Lane WC,
whole cells. Lane OM, outer membrane fraction. Lane PP, periplasm fraction. Lane IM, inner membrane
fraction. Lane CY, cytoplasm fraction. (b) Mass-spectrometric sequence coverage of YfeA, shown in green,
in the whole-cell and periplasm fractions. (c) Mass spectrum of YfeB in the whole-cell fraction.
bound to site 2. All structures with a metal-bound site 2
belonged to crystal form 2.
3.5. YfeA can freely bind zinc from bulk solvent at
low-affinity ancillary metal-binding sites
Crystal-soaking experiments were performed using
manganese, iron with -mercaptoethanol, and zinc. Since
YfeA contains no disulfide bonds, reducing agents do not
perturb its structure. Similarly to co-crystallization experi-
ments, only one type of metal in the soaking experiments
showed metal binding to YfeA. Soaks in zinc yielded crystals
with surface ancillary metal-bound sites; however, back-
soaking experiments in crystallization buffer void of zinc were
able to remove the metal from all of the ancillary sites,
suggesting that these sites are exchangeable. From these
experiments, a total of nine sites were discovered: Glu106,
Glu110, Glu131, Asp164, His167, Glu169, Gln176, Glu199 and
Glu270 (Figs. 8c and 8d). Given that these sites can only be
loaded through soaking, co-crystallization experiments with
zinc may have immediately precipitated YfeA because the
additional Zn atoms that bind each YfeA molecule may have
had a deleterious effect on the electrostatics that would have
otherwise stabilized crystal packing. Metal loading at ancillary
sites varies according to state of site 2. When site 2 is apo,
Glu106, Glu110, Gln176, Glu199 and Glu270 can be loaded
(Fig. 8c), whereas when site 2 is metal-bound Glu131, Asp164,
His167 and Glu169 can be loaded (Fig. 8d). It is interesting
that the ancillary sites that can be co-loaded with site 2 are
predominantly in the immediate proximity of site 2, whereas
the ancillary sites that do not co-load with site 2 are distant
from site 2 (Figs. 8c and 8d).
3.6. YfeA in the context of the Yfe transporter is
predominantly zinc-bound
To explore the structure of metal binding of YfeA in protein
co-expressed with its downstream physiological partners,
YfeBCDE, wild-type untagged YfeA was purified from the
periplasm of an E. coli strain expressing the Yfe transporter
via the previously characterized vector pYFE3, which contains
the Yfe locus cloned from the Y. pestis genome (Bearden et al.,
1998; Bearden & Perry, 1999). Biochemical testing has shown
that an E. coli strain harboring this vector is able to grow on
EDDA-chelated medium that would otherwise abrogate
growth; however, mutagenesis experiments on this vector
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Figure 10
YfeA flexibility. The YfeA c-clamp is not entirely rigid. (a) Cartoon representation of YfeA illustrating the positions of the flexible helix and flexible
loops relative to site 1 and site 2. (b) Superimposition of crystal forms colored by B factor shows subtle changes in the flexible loops and identifies a lone
flexible helix in the carboxy-terminal lobe, annotated the ‘flexible lobe’. The absence of a flexible helix in the amino-terminal lobe suggests that this lobe
is a ‘rigid lobe’. (c) Orthogonal view of (b) showing the proximity of the flexible helix and loop 223–233 relative to site 1. (d) Enlarged image of (b) at site
1 showing that ligands do not change position across crystal forms.
indicate that all of the YfeABCDE components are required
for growth, suggesting that pYFE3 recapitulates the full,
functional Yfe transporter in E. coli (Bearden et al., 1998;
Bearden & Perry, 1999). Therefore, the YfeA produced from
pYFE3 in E. coli is free to interact with its natural binding
partners and produce a physiological metal signature. Under
these conditions, native YfeA was purified by cell fractiona-
tion (Fig. 9a) followed by anion-exchange and gel-filtration
chromatography. Mass spectrometry confirmed the presence
of the YfeA and YfeB components in whole cells, and only the
YfeA component in the periplasm fraction (Figs. 9b and 9c).
Further justification of our use of E. coli to produce relevant
native YfeA protein was our finding that pre-pro YfeA was
properly secreted to the periplasm with a cleaved signal
peptide that was not present in the crystals of YfeA protein
and was not detected by mass spectrometry. X-ray scattering
data from ten crystals revealed that native YfeA crystallizes in
the 42  52  113 Å crystal form. EDS spectra of native
untagged YfeA crystals showed that the primary substrate at
site 1 is zinc, with a slightly stronger signal from iron but
surprisingly no signal from manganese (Fig. 6). Mysteriously,
one out of 50 crystals gave a negligible EDS signature for all
metals, indicating the stochastic nature of observing physio-
logical apoprotein and suggesting the possibility of achieving
apoprotein without the need for mutagenesis, partial dena-
turation or chelating agents. This alternative strategy instead
requires the co-expression of binding partners and careful
technique to extract protein while avoiding the reintroduction
of the metal substrate that cluster A-1 SBPs can sponta-
neously bind. Efforts are currently under way to reproduce
diffraction-quality crystals of this potentially apo YfeA.
3.7. Minor conformational changes in the flexible loops
Trp96–Trp104, Val119–Pro140 and Tyr223–Gly233 and in
helix 7 suggest that structural rearrangement occurs during
metal loading and unloading
In this study, three crystal forms of YfeA were discovered,
with minor differences between their respective structures
(Fig. 10). Superimposition of the three crystal forms reveals
minor conformational changes in the three flexible loops that
flank site 1 (Figs. 10b and 10c), and B-factor analysis identifies
a flexible helix, helix 7, that may participate in structural
reorganization of the carboxy-terminal lobe during metal
transfer (Fig. 10b). The B factors for atoms in helix 7 reach a
maximum in the 62  66  67 Å crystal form. The structural
changes in the flexible loops all occur on the same face of the
YfeA molecule, which is also the face that contains site 2
(Fig. 10a). Crystal form 1 contains changes in loops 96–104 and
223–233, which deviate from their positions in crystal forms 2
and 3 (Figs. 10b and 10c). Loop 119–140 in crystal form 3 (the
crystal form that arises from YfeA–EDTA co-crystallization)
shows the greatest deviation from the other crystal forms.
Although loop changes across crystal forms occur in close
vicinity to site 1, there is a negligible perturbation of site 1
(Fig. 10d). The concentration of these features on one face of
the YfeA molecule but not the other may indicate the loca-
lization of a pipeline of allosteric changes extending from site
2 to site 1 (Fig. 10a). Furthermore, these changes may reflect a
greater degree of structural flexibility in cluster A-1 SBPs than
may be anticipated.
4. Discussion
YfeA is a polyspecific cluster A-1 SBP that is important for
Y. pestis infection and transition-metal homeostasis (Bearden
& Perry, 1999; Desrosiers et al., 2010; Fetherston et al., 2012;
Perry et al., 2012). YfeA contains a canonical metal-binding
site that we refer to as site 1, with ligands that are evolutio-
narily conserved across SBPs from Gram-positive and Gram-
negative genera (Fig. 5). EDS and anomalous X-ray scattering
data confirm that site 1 binds zinc, iron and manganese in a
manner that appears to be irreversible in the absence of
physiological downstream binding partners for metal
exchange. Site 1 appears to show a preference for zinc across
all growth-condition experiments, including conditions where
YfeA is produced in the context of its cognate transporter. It
may be possible to achieve higher occupancies of manganese
or iron by either adding more metal at the time of induction
and harvesting cells sooner, or continuously supplementing
with metal over the course of overexpression. However, such
experiments would deviate from the physiological setting
considerably given that the host and pathogen compete for
limited metal nutrients.
Indeed, YfeA has been shown to bind zinc with high affinity
but does not contribute to zinc accumulation in Y. pestis
(Desrosiers et al., 2010). To our knowledge, however, direct
zinc-transport activity from the Yfe transporter, i.e. by 65Zn
uptake, has not been measured. We cannot therefore distin-
guish between the possibility of potentially novel zinc-
transport activity in YfeA and an artefactual interaction. We
consider that our results highlight the phenomenon of the
mismetallation of enzymes (Imlay, 2014) owing to the zinc
occupancy being higher than those of manganese and iron in
YfeA, which is a putative manganese and iron chaperone.
Although oxidative stress is known to highly exacerbate
mismetallation in mononuclear enzymes (Imlay, 2014), E. coli
was not under oxidative stress to produce YfeA for this
crystallographic study. Here, the cells were shaken heavily in
an aerobic environment, and initially iron was not deficient,
yet zinc was still the primary occupant at site 1. We are
therefore unable to distinguish between mismetallization of
YfeA with zinc or the more exciting possibility that YfeA,
under some circumstances, may make some contribution to
zinc uptake. Given that zinc is ubiquitous, under the condi-
tions of YfeA overexpression the initial formation of
apoprotein could lead to adventitious binding of zinc that is
unrelated to any biological function. This could occur when
the native metal substrate is relatively scarce or requires a
chaperone for incorporation. For example, native azurin is a
copper-binding periplasmic protein in Pseudomonas aerugi-
nosa that is found to be zinc-bound after overexpression and
purification from E. coli (Nar et al., 1992). Zn-azurin is
considered to be a contaminating byproduct from transport to
research papers
Acta Cryst. (2017). D73, 557–572 Radka et al.  Yersinia pestis virulence factor YfeA 569
the E. coli periplasm and not to be representative of the actual
structure–function of P. aeruginosa Cu-azurin (Nar et al.,
1992). Another example is PsaA, which is a manganese-
binding SBP in Streptococcus pneumoniae that also binds zinc,
although Mn-PsaA and Zn-PsaA are nearly structurally
identical (McDevitt et al., 2011; Couñago et al., 2014).
Biophysical experiments on PsaA revealed that Zn-PsaA is
more thermally stable than Mn-PsaA, and that the affinity of
PsaA for zinc is nearly two orders of magnitude greater than
the affinity of PsaA for manganese (McDevitt et al.,
2011; Couñago et al., 2014). However, intracellular metal-
accumulation measurements indicate that PsaA does not
transport zinc (McDevitt et al., 2011; Couñago et al., 2014).
Intriguingly, PsaA has also been shown to bind and transport
cadmium, in spite of cadmium not being a physiological
substrate (Begg et al., 2015). An alternative explanation for
YfeA being zinc-bound might be that potential apo YfeA
could quickly become metal-bound during cell lysis from
leaked cytoplasmic contents prior to purification, further
complicating the interpretation of bound zinc.
The metal-binding profile for YfeA site 1 can vary
according to environmental conditions, as the relative abun-
dance of any bound substrate can change. Although the profile
of the bound substrate can change, EDTA cannot remove
metal cargo from site 1, even after including EDTA in the
purification buffers, overnight dialysis and co-crystallization.
This suggests that the only way to remove the metal from site 1
is by interaction with downstream YfeA-binding partners and
a major conformational change or degradation mechanism.
The observation that even extensive treatment with EDTA
cannot remove the metal from YfeA site 1 makes YfeA
distinct from other SBPs that have been produced in an apo
state, such as ZinT from Salmonella enterica (Ilari et al., 2014).
In the literature, apo SBPs have been generated through
mutagenesis, partial denaturation and/or EDTA treatment.
Therefore, future studies to produce apo YfeA might include
these strategies as well as overexpression of YfeA in the
context of its endogenous binding partners.
Metal-coordination geometry alone cannot unequivocally
exclude the possibility of binding one metal over another;
however, tetrahedral geometries are known for zinc, iron and
manganese, although they are not as common as other
geometries for iron and manganese (Dokmanić et al., 2008; Tus
et al., 2012). Rubredoxin is an example of an iron-containing
protein with a tetrahedral site (Eaton & Lovenberg, 1970).
PsaA is an example of a manganese-containing protein with a
tetrahedral site, with metal-binding ligands that are accessible
in the apo state and buried in the holo state (Couñago et al.,
2014). In tetracoordinate geometry, zinc, manganese and iron
prefer a tetrahedral or near-tetrahedral geometry in which all
four ligands are orthogonal to each other and provide a
stronger interaction with the metal. Given that tetrahedral
geometry is less common in iron and manganese, the geometry
of YfeA site 1 may influence competitive metal-binding affi-
nities such that when the metal-binding geometry is a poor fit
interaction with this metal is weaker. This may also explain
differences in site 1 metal occupancies as well as the Kd for
YfeA–Zn and YfeA–Mn interactions (Desrosiers et al., 2010),
although the ITC data are confounded by the discovery of site
2 and the ancillary sites. To specifically measure the canonical
site affinity for zinc, manganese or iron, mutagenesis of all of
the other metal-binding sites in this report would be required
for comparative analysis, highlighting the need for rigorous
structural investigation of any SBP and the elucidation of
additional metal-binding sites.
From a coordination-geometry perspective, the hierarchy of
metal binding at site 1 is expected to be Zn >>> Fe > Mn based
on the frequency of tetrahedral geometry observed in protein–
metal binding in the PDB (Dokmanić et al., 2008; Tus et al.,
2012); however, this is a relative binding preference and not an
absolute preference, as the X-ray fluorescence data suggest
that the site 1 metal preference is Zn >>> Mn > Fe. Therefore,
specificity for zinc, manganese or iron at site 1 must not be
determined by coordination geometry but rather by some
other property. In E. coli, the intracellular manganese
concentration is very low relative to those of other metals
during normal growth conditions (Anjem et al., 2009).
However, manganese seems to function as a metabolic
oxidant-resistant substitute for iron in metallating mono-
nuclear enzymes under conditions of iron starvation and
oxidative stress (Anjem et al., 2009). We believe that
manganese serves a similar role in Y. pestis, and that the
Yfe transporter has a physiological preference for manganese
that is greater than that for iron based on the negligible
manganese signal relative to the iron signal in the EDS spectra
of purified native YfeA that was overexpressed in the context
of YfeBCDE. A negligible manganese signal suggests that
manganese transport may be more rapid than iron transport
through YfeBCDE. The Yfe transporter may actually serve as
a conduit to transition between iron-based metabolism and
manganese-based metabolism. We speculate that this key role
is the reason that YfeA is important for virulence and is
upregulated significantly more than other SBPs during
Y. pestis infection. At this time, the role of zinc is
unclear.
Manganese co-crystallization experiments revealed site 2,
which is a surface metal-binding site that prefers to sponta-
neously bind zinc but can spontaneously bind manganese as
well. Zinc can be titrated in a co-crystallization experiment to
increase its occupancy at site 2 but, curiously, manganese is
required for loading. The reason that manganese is required
is unknown and cannot be determined crystallographically.
Back-soaking experiments indicate that site 2 metal loading is
irreversible and only occurs when YfeA is aqueous prior to
crystallization. We speculate that site 2 may play a functional
role in communication with the Yfe transporter. Soaking
YfeA crystals with zinc revealed nine ancillary metal-binding
sites, half of which only load when site 2 is occupied and the
other half of which only load when site 2 is apo. It is curious
that the ancillary sites that load with site 2 mostly occur in the
immediate proximity of site 2 rather than at distal sites on the
molecule. Site 2 and the ancillary sites demonstrate that YfeA
can continue to take up free metal from solution after site 1 is
loaded.
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Site 2 binds manganese and zinc with tetrahedral or near-
tetrahedral geometry by additional coordination from two
water molecules. Cations bound to site 2 in the YfeA crystal
may readily dissociate in solution, particularly because the
free metal concentration in the periplasm is low. The combi-
nation of site 2 being a surface site and the observation of
water molecules coordinating the metal suggests that bound
cations are easily accessible and readily interchangeable,
further supporting a role in communication with the Yfe
transporter. Histidine is the most common recurring ligand
that chelates zinc, iron and manganese in the PDB (Dokmanić
et al., 2008; Tus et al., 2012). The ligands and geometries of sites
1 and 2 may have electronic significance, such as tuning the
redox properties of each site and mitigating metal transfer. At
site 2, we believe that histidine may be the more crucial
ligand and that glutamate may help to tune histidine–metal
binding. Future directions include mutagenesis studies of
site 2 and functional investigation of site 2 in Y. pestis
YfeA.
Metal-soaking experiments were performed using 10 mM
ZnCl2, which is well above the physiological zinc concentra-
tion; thus, occupancy during normal growth conditions may
not occur. Instead, this function may be important under high
(but not toxic) zinc levels when iron or manganese levels are
low (Desrosiers et al., 2010). During infection, an antibacterial
strategy used by phagocytes is respiratory burst, or the rapid
release of highly reactive chemicals designed to be toxic in
nature and to catalyze the formation of additional toxic
chemicals (Slauch, 2011). The ancillary sites may also allow
YfeA to loosely bind Zn atoms and act as a zinc sink when zinc
is in toxic excess, such as during respiratory burst. All YfeA
ancillary metal-binding sites are composed of single ligands
that are likely to be weak chelators; however, given that they
are on the surface and have been shown to interact with zinc,
they may play a role in this speculative activity. Metals in these
ancillary sites can be exchanged via back-soaking, indicating
that binding to these sites is reversible. It is worth noting that
another Y. pestis SBP has been shown to contain multiple
ancillary single-ligand sites, although the relevance of
these sites was proposed to be artefactual (Shouldice et al.,
2005).
A topic of debate in cluster A-1 SBPs is the precise
mechanism of metal loading and unloading at the canonical
metal-binding site. By varying the growth and crystallization
conditions, we observed three subtle conformational changes
in the YfeA flexible loops that flank site 1 and a flexible helix
in the carboxy-terminal lobe. Intriguingly, a flexible loop in
ZnuA that is in a similar position to the YfeA flexible loop
119–140 has been proposed to influence zinc transfer (Wei et
al., 2007). We speculate that a major structural rearrangement
to the c-clamp must be required to unload metal from site 1,
and in the case of YfeA this rearrangement will occur through
helix 7 in the flexible lobe. We anticipate the structurally
rearranged state to be unstable for crystallography, and that
crystallography may actually select for the more stable, intact
c-clamp. Although there may be no metal bound, the observed
apo protein may simply be protein that has structurally
reverted to an intact c-clamp. Structural comparisons of many
apo and metal-bound cluster A-1 SBPs indicate that there
is very little movement in the / domains between the
states (Andrews et al., 2003; Couñago et al., 2012). Should a
structural rearrangement occur during metal transfer that
forces YfeA or other cluster A-1 SBPs into an unstable state
that is not an intact c-clamp, then this might suggest that the
true apo state of cluster A-1 SBPs may not yet have been
observed.
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